IMM 1.72% 29.5¢ immutep limited

Ann: A$80 million fully underwritten equity raising, page-39

  1. 1,600 Posts.
    lightbulb Created with Sketch. 380
    Probably one of the worst managed biotechs.
    They have a great product but totally clueless on how to extract value. They are happy to rape shareholders whenever they feel like it.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.